Collagen Dipeptide Pro-Hyp Identified as Growth Signal for Wound-Healing Fibroblasts

The collagen-derived dipeptide prolylhydroxyproline (Pro-Hyp) selectively triggers growth of stem cell-like fibroblasts at wound sites, explaining why oral collagen supplements accelerate wound healing.

Sato, Kenji et al.·Frontiers in cell and developmental biology·2020·Moderate EvidenceReview
RPEP-05111ReviewModerate Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not applicable (review covering in vitro, animal, and human wound healing studies)
Participants
Not applicable (review covering in vitro, animal, and human wound healing studies)

What This Study Found

Pro-Hyp is a low molecular weight growth-initiating factor that selectively triggers proliferation of p75NTR-positive (stem cell-like) fibroblasts on collagen gel but not p75NTR-negative fibroblasts. Oral collagen/gelatin delivers Pro-Hyp to tissues and accelerates wound healing in animals and humans.

Key Numbers

Pro-Hyp dipeptide; selective for p75NTR+ fibroblasts on collagen; oral bioavailability confirmed; improves pressure ulcers and diabetic wounds

How They Did This

Review integrating cell biology studies of fibroblast heterogeneity, Pro-Hyp signaling on collagen substrates, and preclinical/clinical evidence for oral collagen supplementation in wound healing.

Why This Research Matters

This provides a molecular explanation for why collagen supplements help wounds heal — a connection that was observed clinically but not mechanistically understood. It also identifies Pro-Hyp as a targetable factor for chronic wound therapy.

The Bigger Picture

This is a rare example of a food-derived bioactive peptide with a clearly identified molecular target and clinical evidence, bridging nutraceutical science with wound healing biology.

What This Study Doesn't Tell Us

Review — summarizes existing evidence without new data. The p75NTR selectivity mechanism needs further elucidation. Optimal Pro-Hyp doses for clinical wound healing not standardized.

Questions This Raises

  • ?What is the receptor or signaling pathway through which Pro-Hyp activates p75NTR-positive fibroblasts?
  • ?Could topical Pro-Hyp application be more effective than oral collagen for wound healing?
  • ?Does Pro-Hyp play a role in other collagen-dependent repair processes like tendon healing?

Trust & Context

Key Stat:
Selective fibroblast activation Pro-Hyp activates wound-healing stem cell-like fibroblasts while leaving healthy tissue fibroblasts quiescent
Evidence Grade:
Moderate — integrates cell biology with preclinical and clinical wound healing evidence, providing a mechanistic framework for observed clinical benefits.
Study Age:
Published in 2020; understanding of collagen peptide bioactivity continues to deepen.
Original Title:
Collagen-Derived Di-Peptide, Prolylhydroxyproline (Pro-Hyp): A New Low Molecular Weight Growth-Initiating Factor for Specific Fibroblasts Associated With Wound Healing.
Published In:
Frontiers in cell and developmental biology, 8, 548975 (2020)
Database ID:
RPEP-05111

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Can taking collagen supplements actually help heal wounds?

Yes — clinical trials show oral collagen/gelatin supplements improve healing of pressure ulcers in humans and diabetic wounds in animals. This review identifies Pro-Hyp, a dipeptide absorbed from digested collagen, as the active mechanism.

How does a tiny two-amino-acid peptide from food reach wound sites?

When you eat collagen or gelatin, digestive enzymes break it into small peptides including Pro-Hyp. This dipeptide is absorbed intact from the gut into the bloodstream and delivered to tissues including wound sites, where it signals stem cell-like fibroblasts to grow and repair.

Read More on RethinkPeptides

Cite This Study

RPEP-05111·https://rethinkpeptides.com/research/RPEP-05111

APA

Sato, Kenji; Asai, Tomoko T; Jimi, Shiro. (2020). Collagen-Derived Di-Peptide, Prolylhydroxyproline (Pro-Hyp): A New Low Molecular Weight Growth-Initiating Factor for Specific Fibroblasts Associated With Wound Healing.. Frontiers in cell and developmental biology, 8, 548975. https://doi.org/10.3389/fcell.2020.548975

MLA

Sato, Kenji, et al. "Collagen-Derived Di-Peptide, Prolylhydroxyproline (Pro-Hyp): A New Low Molecular Weight Growth-Initiating Factor for Specific Fibroblasts Associated With Wound Healing.." Frontiers in cell and developmental biology, 2020. https://doi.org/10.3389/fcell.2020.548975

RethinkPeptides

RethinkPeptides Research Database. "Collagen-Derived Di-Peptide, Prolylhydroxyproline (Pro-Hyp):..." RPEP-05111. Retrieved from https://rethinkpeptides.com/research/sato-2020-collagenderived-dipeptide-prolylhydroxyproline-prohyp

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.